Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-12-06

Clinical Trial Update: Carfilzomib/Cyclophosphamide/Dexamethasone with Maintenance Carfilzomib in Multiple Myeloma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of carfilzomib, cyclophosphamide, and dexamethasone with maintenance carfilzomib in multiple myeloma; the study status is ACTIVE_NOT_RECR…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CYCLOPHOSPHAMIDE (Cyclophosphamide)
  • Carfilzomib (carfilzomib)
  • DEXAMETHASONE (Dexamethasone)

Snippet

Sponsor: University College, London | Conditions: Multiple Myeloma | Phase 2 | Status: ACTIVE_NOT_RECRUITING